Oncology
Average per capita Essential Innovative Medicine use in Europe across therapy clusters, 2021
To explore by country, see World map
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
800
Range of European values
U.S.
Above median GDP/capita
Below median GDP/capita
58
82
36
38
45
100
21
700
600
500
400
300
200
100
0
Hover over graph to view values
Hover over legend to isolate data groups
125
138
265
439
175
189
210
142
117
163
159
152
100
175
Back to Main graph
ONCOLOGY
DIABETES
IMMUNOLOGY
neurology
CARDIOVASCULAR
Hepatitis C
Cystic Fibrosis
Austria
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
196
135
281
173
332
64
317
Oncology
Diabetes
Immunology
CNS
Cardiovascular
Hep C
Cystic Fibrosis
1 / 35
Data for U.s.
BELARUS
15
1
5
0
15
515
0
2 / 35
BELGIUM
186
92
214
131
157
44
108
3 / 35
BULGARIA
90
65
64
36
30
50
10
5 / 35
Belgium
Austria
Bosnia
Belarus
Oncology
Austria
France
Belgium
Slovenia
Germany
Switzerland
Italy
Denmark
Spain
Sweden
U.S.
Norway
U.K.
Lithuania
Ireland
Croatia
Hungary
Netherlands
196
193
186
175
175
168
164
148
130
128
125
120
117
116
115
115
107
104
ONCOLOGY
FINLAND
PORTUGAL
BULGARIA
CZECH REPUBLIC
ROMANIA
SLOVAKIA
POLAND
TURKEY
LATVIA
SERBIA
BOSNIA
RUSSIA
BELARUS
UKRAINE
KAZAKHSTAN
ESTONIA
LUXEMBOURG
GREECE
100
98
90
74
72
70
56
43
42
24
20
19
15
10
8
—
—
—
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Bosnia
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
20
26
5
9
10
21
0
4 / 35
Croatia
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
115
120
84
150
47
0
0
6 / 35
CZECH REPUBLIC
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
74
95
65
159
86
121
130
7 / 35
Estonia
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
—
137
6
67
56
395
0
9 / 35
Finland
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
100
194
161
282
134
206
42
10 / 35
France
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
193
99
131
107
84
51
264
11 / 35
Germany
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
175
155
239
176
204
40
359
12 / 35
Greece
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
—
241
2
3
68
—
0
13 / 35
Hungary
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
107
95
36
24
59
5
60
14 / 35
Ireland
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
115
96
183
44
93
53
0
15 / 35
Italy
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
164
80
129
105
135
131
130
16 / 35
KAZAKHSTAN
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
8
17
0
5
7
190
0
17 / 35
Latvia
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
42
85
16
32
31
278
0
18 / 35
Lithuania
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
116
29
24
162
61
249
0
19 / 35
LUXEMBOURG
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
—
228
336
245
259
—
0
20 / 35
Netherlands
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
104
40
109
38
252
20
225
21 / 35
Norway
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
120
143
131
421
175
71
53
22 / 35
Poland
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
56
31
11
21
50
52
1
23 / 35
Portugal
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
98
242
60
56
97
99
61
24 / 35
Romania
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
72
84
27
18
34
34
1
25 / 35
Russia
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
19
15
23
27
20
59
4
26 / 35
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
24
20
17
25
10
—
0
27 / 35
Serbia
Slovakia
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
70
56
100
78
118
21
105
28 / 35
Slovenia
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
175
94
160
136
127
34
146
29 / 35
Spain
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
130
176
133
125
121
100
116
30 / 35
Sweden
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
128
113
168
117
202
57
88
31 / 35
Switzerland
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
168
130
265
236
203
59
0
32 / 35
Turkey
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
43
117
25
36
44
0
0
33 / 35
United Kingdom
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
117
99
120
53
100
54
755
34 / 35
Ukraine
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
10
6
0
0
5
84
0
35 / 35
Bosnia
Bulgaria
Croatia
Czech Republic
Denmark
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
148
145
126
207
119
44
527
8 / 35
Denmark
Estonia
Diabetes
Diabetes
Portugal
Greece
Luxembourg
Finland
Spain
Germany
Denmark
Norway
U.S.
Estonia
Austria
Switzerland
Croatia
Turkey
Sweden
France
U.K.
Ireland
242
241
228
194
176
155
145
143
138
137
135
130
120
117
113
99
99
96
HUNGARY
CZECH REP.
SLOVENIA
BELGIUM
LATVIA
ROMANIA
ITALY
BULGARIA
SLOVAKIA
NETHERLANDS
POLAND
LITHUANIA
BOSNIA
SERBIA
KAZAKHSTAN
RUSSIA
UKRAINE
BELARUS
95
95
94
92
85
84
80
65
56
40
31
29
26
20
17
15
6
1
Russia
Finland
Sweden
Norway
Ireland
U.K.
Portugal
Spain
France
Italy
Greece
Ukraine
Immunology
IMMUNOLOGY
Luxembourg
Austria
U.S.
Switzerland
Germany
Belgium
Ireland
Sweden
Finland
Slovenia
Spain
Norway
France
Italy
Denmark
U.K.
Netherlands
Slovakia
336
281
265
265
239
214
183
168
161
160
133
131
131
129
126
120
109
100
CROATIA
CZECH REP.
BULGARIA
PORTUGAL
HUNGARY
ROMANIA
TURKEY
LITHUANIA
RUSSIA
SERBIA
LATVIA
POLAND
ESTONIA
BOSNIA
BELARUS
GREECE
KAZAKHSTAN
UKRAINE
84
65
64
60
36
27
25
24
23
17
16
11
6
5
5
2
0
0
Neurology
Neurology
U.s.
NORWAY
FINLAND
LUXEMBOURG
SWITZERLAND
DENMARK
GERMANY
AUSTRIA
LITHUANIA
CZECH REPUBLIC
CROATIA
SLOVENIA
BELGIUM
SPAIN
SWEDEN
FRANCE
ITALY
SLOVAKIA
439
421
282
245
236
207
176
173
162
159
150
136
131
125
117
107
105
78
ESTONIA
PORTUGAL
UK
IRELAND
NETHERLANDS
BULGARIA
TURKEY
LATVIA
RUSSIA
SERBIA
HUNGARY
POLAND
ROMANIA
BOSNIA
KAZAKHSTAN
GREECE
BELARUS
UKRAINE
67
56
53
44
38
36
36
32
27
25
24
21
18
9
5
3
0
0
Cardiovascular
Cardiovascular
Austria
Luxembourg
Netherlands
Germany
Switzerland
Sweden
U.S.
Norway
Belgium
Italy
Finland
Slovenia
Spain
Denmark
Slovakia
U.K.
Portugal
Ireland
332
259
252
204
203
202
175
175
157
135
134
127
121
119
118
100
97
93
CZECH REP.
FRANCE
GREECE
LITHUANIA
HUNGARY
ESTONIA
POLAND
CROATIA
TURKEY
ROMANIA
LATVIA
BULGARIA
RUSSIA
BELARUS
SERBIA
BOSNIA
KAZAKHSTAN
UKRAINE
86
84
68
61
59
56
50
47
44
34
31
30
20
15
10
10
7
5
Hepatitis C
Hepatitis C
Belarus
Estonia
Latvia
Lithuania
Finland
Kazakhstan
U.S.
Italy
Czech Rep.
Spain
Portugal
Ukraine
Norway
Austria
Switzerland
Russia
Sweden
U.K.
515
395
278
249
206
190
189
131
121
100
99
84
71
64
59
59
57
54
IRELAND
POLAND
FRANCE
BULGARIA
BELGIUM
DENMARK
GERMANY
SLOVENIA
ROMANIA
SLOVAKIA
BOSNIA
NETHERLANDS
HUNGARY
CROATIA
TURKEY
LUXEMBOURG
GREECE
SERBIA
53
52
51
50
44
44
40
34
34
21
21
20
5
0
0
—
—
—
Cystic fibrosis
Cystic fibrosis
U.K.
Denmark
Germany
Austria
France
Netherlands
U.S.
Slovenia
Italy
Czech Republic
Spain
Belgium
Slovakia
Sweden
Portugal
Hungary
Norway
Finland
755
527
359
317
264
225
210
146
130
130
116
108
105
88
61
60
53
42
BULGARIA
RUSSIA
POLAND
ROMANIA
BELARUS
ESTONIA
LATVIA
LITHUANIA
KAZAKHSTAN
UKRAINE
SWITZERLAND
IRELAND
BOSNIA
CROATIA
TURKEY
LUXEMBOURG
GREECE
SERBIA
10
4
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Germany
Hungary
Kazakhstan
Latvia
Lithuania
LUXEMBOURG
Netherlands
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland
Turkey
To view all country values, select a therapy cluster to the left. To view individual country values, select a country below.
Notes: Medicine use measured in defined daily doses. U.S. shown for comparison only. Countries were categorized above and below median GDP per capita, using median of GDP per capita of 35 European countries.
Notes: Medicine use measured in defined daily doses. U.S. shown for comparison only. Analyses are based on IQVIA audited data. In countries where IQVIA only audits retail channels or where medicines are distributed through unique mechanisms, index values were not calculated for specific therapy clusters and are noted with a dash.
Tap graph to view more
Notes: Medicine use measured in defined daily doses. U.S. shown for comparison only. Analyses are based on IQVIA audited data. In countries where IQVIA only audits retail channels or where medicines are distributed through unique mechanisms, index values were not calculated for specific therapy clusters and are noted with a dash.
Indexed to Europe average = 100
Tap graph to view more
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis
Oncology
Diabetes
Immunology
Neurology
Cardiovascular
Hepatitis C
Cystic Fibrosis